CANF logo

Can-Fite BioPharma (CANF) Company Overview

Profile

Full Name:

Can-Fite BioPharma Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

November 6, 2012

Indexes:

Not included

Website:

http://www.canfite.com

Description:

Can-Fite BioPharma is a biotechnology company that develops innovative treatments for cancer and inflammatory diseases. They focus on discovering and advancing new drugs that target specific receptors in the body, aiming to improve patient outcomes and quality of life. Their research includes clinical trials and partnerships with other organizations.

Key Details

Price

$1.55

Market Cap

$9.45 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$743.00 K(-8.27% YoY)

Annual EPS

-$3.00(0.00% YoY)

PE Ratio

-

Annual ROE

-142.49%

Annual Debt To Equity

0.00

Beta

0.72

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Aug 29, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 9, 2023

Analyst ratings

Recent major analysts updates

Mar 3, 25 D. Boral Capital
Buy
Feb 18, 25 D. Boral Capital
Buy
Dec 31, 24 D. Boral Capital
Buy
Dec 5, 24 D. Boral Capital
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Jul 17, 24 EF Hutton
Buy
May 9, 24 HC Wainwright & Co.
Buy
Oct 24, 23 HC Wainwright & Co.
Buy
Jun 2, 23 HC Wainwright & Co.
Buy
Mar 13, 23 HC Wainwright & Co.
Buy

Screeners with CANF included

Growing Shares Outstanding
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Israeli stocks
NYSE American Exchange Companies

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.55
CANF price is $1.55

Price All-time High

$1290.00
CANF price is currently -99.88% below its historical high of $1290.00

Price Analysts Target

$14.00
CANF price is currently -88.93% lower than the consensus analysts' forecast

Price Today Change

+1.31%
CANF price is up +1.31% today

Price YTD Change

-4.32%
CANF price is down -4.32% since January 1st

Price 3-Year Change

-84.02%
CANF price is down -84.02% over the past 3 years

Market cap

Market Cap

$9.45 M
CANF market capitalization is $9.45 million

Market Cap 3-Year Change

-64.17%
CANF market capitalization is down -64.17% over the past 3 years

Market Cap All-time High

$61.40 M
CANF market capitalization is currently -84.61% below its historical high of $61.40 million

Market Cap Sector Rank

18.6%
CANF market capitalization is higher than 18.6% of companies in Healthcare sector

Technical

Beta

0.72
CANF beta is 0.72

200-day SMA

$2.23
CANF price is currently -30.34% below its 200-day simple moving average

14-day RSI

42.02
CANF 14-day relative strength index is 42.02

30-day Relative Volume

0.49
CANF 30-day relative volume is 0.49

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$743.00 K
CANF annual revenue is $743.00 thousand

Annual Revenue Analysts Estimate

$500.00 K
CANF annual revenue is currently +48.60% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-8.27%
CANF annual revenue is down -8.27% year-on-year

Annual Revenue Sector Rank

11.3%
CANF annual revenue is higher than 11.3% of companies in Healthcare sector

Profit

Annual Gross Profit

-
CANF annual gross profit value is unknown

Annual Gross Margin

-
CANF annual gross profit margin value is unknown

Annual Operating Profit

-$8.20 M
CANF annual operating income is -$8.20 million

Annual Operating Margin

-1102.96%
CANF annual operating profit margin is -1102.96%

Annual Net Income

-$7.63 M
CANF annual net profit is -$7.63 million

Annual Net Margin

-1027.46%
CANF annual net profit margin is -1027.46%

EPS

Annual EPS

-$3.00
CANF annual earnings per share is -$3.00

Annual EPS Analysts Estimate

-
CANF annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

0%
CANF {parameterFullLabel} has remained unchanged year-on-year

Annual EPS Sector Rank

32.4%
CANF annual earnings per share is higher than 32.4% of companies in Healthcare sector

ROA & ROE

Annual ROA

-79.22%
CANF annual return on assets is -79.22%

Annual ROE

-142.49%
CANF annual return on equity is -142.49%

EBIT & EBITDA

Annual EBIT

-$8.20 M
CANF annual earnings before interest & taxes is -$8.20 million

Annual EBITDA

-$8.18 M
CANF annual EBITDA is -$8.18 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CANF price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CANF price to earnings ratio is unknown

PB Ratio

PB Ratio

3.81
CANF price to book ratio is 3.81

PB Ratio Sector Rank

76.52%
CANF price to book ratio is higher than 76.52% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CANF price to sales ratio value is unknown

PS Ratio Sector Rank

-
CANF price to sales ratio is unknown

Enterprise value

Enterprise Value

$4.79 M
CANF enterprise value is $4.79 million

Enterprise Value Sector Rank

18.76%
CANF enterprise value is higher than 18.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
CANF EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
CANF EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.91
CANF annual current ratio is 4.91

Annual Quick Ratio

-
CANF annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
CANF annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
CANF annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CANF piotroski f-score value is unknown

Altman Z-Score

-22.38
CANF altman z-score is -22.38

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$9.99 M
CANF annual total assets is $9.99 million

Annual Non Current Assets

$81.00 K
CANF annual long term assets is $81.00 thousand

Annual Current Assets

$9.91 M
CANF annual total current assets is $9.91 million

Annual Cash & Cash Equivalents

$4.28 M
CANF annual cash & cash equivalents is $4.28 million

Equity

Annual Book Value

$6.24 M
CANF annual book value is $6.24 million

Annual Working Capital

$7.89 M
CANF annual working capital is $7.89 million

Liabilities

Annual Total Liabilities

$3.75 M
CANF annual total liabilities is $3.75 million

Annual Total Long Term Liabilities

$1.73 M
CANF annual total long term liabilities is $1.73 million

Annual Current Liabilities

$2.02 M
CANF annual total current liabilities is $2.02 million

Annual Accounts Payable

$427.00 K
CANF annual accounts payable is $427.00 thousand

Debt

Annual Total Debt

$40.00 K
CANF annual total debt is $40.00 thousand

Annual Total Debt 1-Year Change

-35.48%
CANF annual total debt is down -35.48% year-on-year

Annual Long Term Debt

$13.00 K
CANF annual long term debt is $13.00 thousand

Annual Short Term Debt

$27.00 K
CANF annual short term debt is $27.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$8.94 M
CANF annual total expenses is $8.94 million

Annual Operating Expenses

$8.94 M
CANF annual total operating expenses is $8.94 million

Annual Cost Of Goods Sold

-
CANF annual cost of goods sold value is unknown

Annual SGA

$2.96 M
CANF annual SGA is $2.96 million

Annual D&A

$15.00 K
CANF annual depreciation & amortization is $15.00 thousand

Annual Interest Expense

-
CANF annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$8.44 M
CANF annual cash flow from operations is -$8.44 million

Annual CFO 1-Year Change

+21.86%
CANF annual cash flow from operations is up +21.86% year-on-year

Annual CFI

$498.00 K
CANF annual cash flow from investing activities is $498.00 thousand

Annual CFI 1-Year Change

-94.76%
CANF annual cash flow from investing activities is down -94.76% year-on-year

Annual CFF

$9.14 M
CANF annual cash flow from financing activities is $9.14 million

Annual CFF 1-Year Change

+100%
CANF annual cash flow from financing activities is up +100% year-on-year

Free CashFlow

Annual FCF

-$8.44 M
CANF annual free cash flow is -$8.44 million

Annual FCF 1-Year Change

+21.91%
CANF annual free cash flow is up +21.91% year-on-year

CAPEX

Annual CAPEX

$2000.00
CANF annual capital expenditures is $2000.00

Annual CAPEX 1-Year Change

-77.78%
CANF annual capital expenditures is down -77.78% year-on-year

Institutional Ownership

Similar stocks

Mobile-health Network Solutions Class A (MNDR)
TXMD logo
TherapeuticsMD (TXMD)
KPRX logo
Kiora Pharmaceuticals (KPRX)
LUCY logo
Innovative Eyewear (LUCY)
Neuphoria Therapeutics (NEUP)
BCLI logo
Brainstorm Cell Therapeutics (BCLI)
TLPH logo
Talphera (TLPH)
WORK Medical Technology Group LTD (WOK)
PAVM logo
PAVmed (PAVM)

FAQ

  • What is the ticker symbol for Can-Fite BioPharma?
  • Does Can-Fite BioPharma pay dividends?
  • What sector is Can-Fite BioPharma in?
  • What industry is Can-Fite BioPharma in?
  • What country is Can-Fite BioPharma based in?
  • When did Can-Fite BioPharma go public?
  • Is Can-Fite BioPharma in the S&P 500?
  • Is Can-Fite BioPharma in the NASDAQ 100?
  • Is Can-Fite BioPharma in the Dow Jones?
  • When was Can-Fite BioPharma's last earnings report?
  • When does Can-Fite BioPharma report earnings?
  • Should I buy Can-Fite BioPharma stock now?

What is the ticker symbol for Can-Fite BioPharma?

The ticker symbol for Can-Fite BioPharma is NYSE American:CANF

Does Can-Fite BioPharma pay dividends?

No, Can-Fite BioPharma does not pay dividends

What sector is Can-Fite BioPharma in?

Can-Fite BioPharma is in the Healthcare sector

What industry is Can-Fite BioPharma in?

Can-Fite BioPharma is in the Biotechnology industry

What country is Can-Fite BioPharma based in?

Can-Fite BioPharma is headquartered in Israel

When did Can-Fite BioPharma go public?

Can-Fite BioPharma's initial public offering (IPO) was on November 6, 2012

Is Can-Fite BioPharma in the S&P 500?

No, Can-Fite BioPharma is not included in the S&P 500 index

Is Can-Fite BioPharma in the NASDAQ 100?

No, Can-Fite BioPharma is not included in the NASDAQ 100 index

Is Can-Fite BioPharma in the Dow Jones?

No, Can-Fite BioPharma is not included in the Dow Jones index

When was Can-Fite BioPharma's last earnings report?

Can-Fite BioPharma's most recent earnings report was on Aug 29, 2024

When does Can-Fite BioPharma report earnings?

The next expected earnings date for Can-Fite BioPharma is Mar 28, 2025

Should I buy Can-Fite BioPharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions